The 25th International AIDS Conference took place in Munich from 22 to 26 July. More than 10,000 guests from all over the world gathered in Munich. The five-day meeting brought together people living
Different groups of TB bacteria exist worldwide with different regional distribution: some are generalists and can be found on many continents, while others are very limited in their spread. An
More than 170 researchers and clinicians from the eight German Centers for Health Research (DZGs) and invited guests from the world of politics shared insights on current DZG research projects at the
The novel active agent HY-133, which was developed by HYpharm and prepared for clinical trials in collaboration with the German Center for Infection Research (DZIF) and universities in Tübingen
The motto of this year's World Hepatitis Day, proclaimed annually on 28 July by the World Health Organisation (WHO), is “It's time to act". Hundreds of millions of people worldwide are affected by
In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus-infected cells but are inactive. An international team led by Percy Knolle and Ulrike Protzer at the
In the years of the COVID-19 pandemic, the effectiveness of government-ordered measures to contain the pandemic, such as regular testing and the wearing of medical masks, was repeatedly called into
UNITE4TB—an international public-private partnership aiming to accelerate the development of innovative tuberculosis treatments—has announced the successful completion of participant recruitment for
Treatment with Linezolid, an antibiotic that is used against multi-resistant tuberculosis bacteria, leads to adverse drug reactions in around a quarter of patients, including certain nerve disorders
"Infektiopod", a podcast in German language that has been providing information on human infectious diseases since 2019, is now being funded by the German Center for Infection Research (DZIF). The